Kieger Sustainable Healthcare Fund Class A USD Accumulating

Reference Data

ISIN LU0996778642
Valor Number 58920661
Bloomberg Global ID
Fund Name Kieger Sustainable Healthcare Fund Class A USD Accumulating
Fund Provider Kieger AG Kieger AG
Limmatstrasse 264, CH-8005 Zürich
Phone: +41 44 444 18 44
Web: https://kieger.com/
E-Mail: info@kieger.com
Fund Provider Kieger AG
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). No guarantee can be given that the investment objective will be achieved.
Peculiarities

Fund Prices

Current Price * 209.20 USD 07.05.2025
Previous Price * 209.41 USD 06.05.2025
52 Week High * 239.55 USD 30.08.2024
52 Week Low * 198.67 USD 07.04.2025
NAV * 209.20 USD 07.05.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 297,382,533
Unit/Share Assets *** 24,504,788
Trading Information SIX

Performance

YTD Performance +0.82% 31.12.2024
07.05.2025
YTD Performance (in CHF) -8.56% 31.12.2024
07.05.2025
1 month +5.30% 07.04.2025
07.05.2025
3 months -5.85% 07.02.2025
07.05.2025
6 months -5.46% 07.11.2024
07.05.2025
1 year -3.77% 07.05.2024
07.05.2025
2 years +3.47% 08.05.2023
07.05.2025
3 years +15.43% 10.05.2022
07.05.2025
5 years +38.63% 12.05.2020
07.05.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 6.56%
Abbott Laboratories 5.73%
AstraZeneca PLC 4.97%
Novartis AG Registered Shares 4.87%
UnitedHealth Group Inc 4.71%
Roche Holding AG 4.69%
Novo Nordisk AS Class B 4.44%
Thermo Fisher Scientific Inc 4.27%
Vertex Pharmaceuticals Inc 3.96%
Boston Scientific Corp 3.66%
Last data update 28.02.2025

Cost / Risk

TER *** 0.99%
TER date *** 30.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 0.85%
Ongoing Charges *** 0.99%
SRRI ***
SRRI date *** 30.04.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)